Fig 1: Thr19 of Lamin A/C is a substrate of CDK1 kinase.A, nocodazole-arrested miotic HeLa cells were additionally treated with DMSO or Ro3306 for 30 min. Subsequently, the cells were harvested and the lysates were subjected to Western blotting analysis using the indicated antibodies, in which thymidine-arrested G1/S phase cells were included as control. B, quality assessment of recombinant 6xHis-tagged Lamin A-WT, T19A, and S22A mutants, which were purified from bacteria for in vitro kinase assay, by means of SDS-PAGE electrophoresis and Coomassie Brilliant Blue staining. C, in vitro phosphorylation of the recombinant proteins as in (B), by CDK1 kinase in the absence or presence of the kinase inhibitor Ro3306, was conducted and applied to Western blotting analyses with the indicated antibodies. Ponceau S staining of the Lamin A proteins was shown as loading control. D, mass spectrometry (LC-MS/MS) was employed to analyze the phosphorylated residues of the CDK1-treated Lamin A.
Fig 2: The N-terminal and C-terminal phosphorylations promote the depolymerization of Lamin A. A, schematic showing the domain organization and the mutation sites of Lamin A-WT and the mutant proteins is presented. B, recombinant GST and GST-tagged Lamin-A-C178-WT and the mutant, that were attached to the glutathione microbeads, were used as matrices to absorb Lamin A-N125-WT and the mutant. Following three washes, the eluates from the microbeads were applied to SDS-PAGE electrophoresis and Coomassie Brilliant Blue staining. C, real-time imaging of the LMNA KO HeLa cells stably expressing GFP-tagged Lamin A-WT and the mutants is representatively showing. The chromosomes were visualized by the co-expressing mCherry-H2B. Scale bar, 10 μm. D, working model accounting for the function of CDK1 phosphorylation of Lamin A is shown.
Supplier Page from Abcam for Recombinant human CDK1 + Cyclin B1 protein (Active) (GST tag N-Terminus)